Clinical Trial Update: Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 umbrella trial evaluating elacestrant in various combination regimens for metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Elacestrant (elacestrant)

Snippet

Sponsor: Stemline Therapeutics, Inc. | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING